Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291617512> ?p ?o ?g. }
- W4291617512 endingPage "42" @default.
- W4291617512 startingPage "27" @default.
- W4291617512 abstract "Human leishmaniasis is an infectious disease caused by Leishmania protozoan parasites. Current chemotherapeutic options against the deadly disease have significant limitations. The ergosterol biosynthetic pathway has been identified as a drug target in Leishmania. However, remarkable differences in the efficacy of antifungal azoles that inhibit ergosterol biosynthesis have been reported for the treatment of leishmaniasis. To better understand the sterol biosynthetic pathway in Leishmania and elucidate the mechanism underlying the differential efficacy of antifungal azoles, we developed a new LC-MS/MS method to study sterol profiles in promastigotes of three Leishmania species, including two L. donovani, one L. major and one L. tarentolae strains. A combination of distinct precursor ion masses and LC retention times allowed for specific detection of sixteen intermediate sterols between lanosterol and ergosterol using the newly developed LC-MS/MS method. Although both posaconazole and fluconazole are known inhibitors of fungal lanosterol 14α-demethylase (CYP51), only posaconazole led to a substantial accumulation of lanosterol in azole-treated L. donovani promastigotes. Furthermore, a key intermediate sterol accumulated by 40- and 7-fold when these parasites were treated with posaconazole and fluconazole, respectively, which was determined as 4α,14α-dimethylzymosterol by high resolution mass spectrometry and NMR spectroscopy. The identification of 4α,14α-dimethylzymosterol supports a branched ergosterol biosynthetic pathway in Leishmania, where lanosterol C4- and C14-demethylation reactions occur in parallel rather than sequentially. Our results suggest that selective inhibition of leishmanial CYP51 is insufficient to effectively prevent parasite growth and dual inhibitors of both CYP51 and the unknown sterol C4-demethylase may be required for optimal antiparasitic effect." @default.
- W4291617512 created "2022-08-15" @default.
- W4291617512 creator A5001755643 @default.
- W4291617512 creator A5001817314 @default.
- W4291617512 creator A5004088208 @default.
- W4291617512 creator A5006973556 @default.
- W4291617512 creator A5014937732 @default.
- W4291617512 creator A5018381369 @default.
- W4291617512 creator A5031895540 @default.
- W4291617512 creator A5041613287 @default.
- W4291617512 creator A5052863964 @default.
- W4291617512 creator A5071949575 @default.
- W4291617512 creator A5073339350 @default.
- W4291617512 date "2022-12-01" @default.
- W4291617512 modified "2023-10-14" @default.
- W4291617512 title "Sterol profiling of Leishmania parasites using a new HPLC-tandem mass spectrometry-based method and antifungal azoles as chemical probes reveals a key intermediate sterol that supports a branched ergosterol biosynthetic pathway" @default.
- W4291617512 cites W1549911162 @default.
- W4291617512 cites W1978129773 @default.
- W4291617512 cites W1979204886 @default.
- W4291617512 cites W1984213432 @default.
- W4291617512 cites W1985868031 @default.
- W4291617512 cites W1987640473 @default.
- W4291617512 cites W1990492545 @default.
- W4291617512 cites W1993632452 @default.
- W4291617512 cites W1996308567 @default.
- W4291617512 cites W2002838459 @default.
- W4291617512 cites W2004875218 @default.
- W4291617512 cites W2007901975 @default.
- W4291617512 cites W2010056868 @default.
- W4291617512 cites W2025509787 @default.
- W4291617512 cites W2026687517 @default.
- W4291617512 cites W2033455856 @default.
- W4291617512 cites W2043446682 @default.
- W4291617512 cites W2044576316 @default.
- W4291617512 cites W2050439504 @default.
- W4291617512 cites W2051143095 @default.
- W4291617512 cites W2056515488 @default.
- W4291617512 cites W2057424462 @default.
- W4291617512 cites W2058184221 @default.
- W4291617512 cites W2062006250 @default.
- W4291617512 cites W2064796591 @default.
- W4291617512 cites W2066207823 @default.
- W4291617512 cites W2071781675 @default.
- W4291617512 cites W2077946350 @default.
- W4291617512 cites W2078505482 @default.
- W4291617512 cites W2080748003 @default.
- W4291617512 cites W2080759878 @default.
- W4291617512 cites W2082722598 @default.
- W4291617512 cites W2103921559 @default.
- W4291617512 cites W2104023897 @default.
- W4291617512 cites W2108144652 @default.
- W4291617512 cites W2113811423 @default.
- W4291617512 cites W2124719726 @default.
- W4291617512 cites W2126265594 @default.
- W4291617512 cites W2136086972 @default.
- W4291617512 cites W2142869187 @default.
- W4291617512 cites W2145904172 @default.
- W4291617512 cites W2147510234 @default.
- W4291617512 cites W2150328121 @default.
- W4291617512 cites W2335014775 @default.
- W4291617512 cites W2338488484 @default.
- W4291617512 cites W2346010708 @default.
- W4291617512 cites W2507534465 @default.
- W4291617512 cites W2592830620 @default.
- W4291617512 cites W2618705397 @default.
- W4291617512 cites W2689455564 @default.
- W4291617512 cites W2750821234 @default.
- W4291617512 cites W2750822783 @default.
- W4291617512 cites W2765777920 @default.
- W4291617512 cites W2777159454 @default.
- W4291617512 cites W2790926941 @default.
- W4291617512 cites W2807185030 @default.
- W4291617512 cites W2809929362 @default.
- W4291617512 cites W2893724706 @default.
- W4291617512 cites W2912981139 @default.
- W4291617512 cites W3009180427 @default.
- W4291617512 cites W3083860583 @default.
- W4291617512 cites W4294618397 @default.
- W4291617512 doi "https://doi.org/10.1016/j.ijpddr.2022.07.003" @default.
- W4291617512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35994895" @default.
- W4291617512 hasPublicationYear "2022" @default.
- W4291617512 type Work @default.
- W4291617512 citedByCount "4" @default.
- W4291617512 countsByYear W42916175122023 @default.
- W4291617512 crossrefType "journal-article" @default.
- W4291617512 hasAuthorship W4291617512A5001755643 @default.
- W4291617512 hasAuthorship W4291617512A5001817314 @default.
- W4291617512 hasAuthorship W4291617512A5004088208 @default.
- W4291617512 hasAuthorship W4291617512A5006973556 @default.
- W4291617512 hasAuthorship W4291617512A5014937732 @default.
- W4291617512 hasAuthorship W4291617512A5018381369 @default.
- W4291617512 hasAuthorship W4291617512A5031895540 @default.
- W4291617512 hasAuthorship W4291617512A5041613287 @default.
- W4291617512 hasAuthorship W4291617512A5052863964 @default.
- W4291617512 hasAuthorship W4291617512A5071949575 @default.
- W4291617512 hasAuthorship W4291617512A5073339350 @default.
- W4291617512 hasBestOaLocation W42916175121 @default.
- W4291617512 hasConcept C136764020 @default.